If you’re reading this, chances are you or someone you know has been affected by the challenges of drug development. Fortunately, there’s a new company on the scene, Preome Industries, that is aiming to transform the clinical success of medicines through the use of predictive super biomarkers. Let’s take a closer look at what Preome is doing to revolutionize the pharmaceutical industry.
What is Preome Industries?
Preome Industries is a UK-based company that specializes in the creation of predictive super signatures and super biomarkers. Their mission is to improve the clinical success of medicines, which is becoming even more critical as medicines continue to become hyper-specific and stratified. The company is based in Stevenage, Herefordshire, and has quickly become one of the top players in the industry.
How Does Preome Industries Work?
Preome is primarily focused on two major issues in the field of drug development. Firstly, animal models have failed to predict the future clinical success of many medicines, resulting in many trials being unsuccessful. Secondly, stratifying a medicine’s response into patient groups is only possible post-approval, which is too late in the development process. Preome is using a predictive super signature, combined with super biomarkers, to provide the most reliable indicator of a medicine’s future clinical success.
What Are Predictive Super Signatures and Super Biomarkers?
Predictive super signatures are ultra-complex signatures that consist of a large number of tests, providing an aggregate result that is more accurate than any individual test alone. The predictive super signature takes into account multiple factors such as genomic information, clinical information, and other relevant data points to predict clinical success. Meanwhile, super biomarkers are the result of the predictive super signature and are biomarkers that are linked to future clinical success. Super biomarkers are used to stratify patients into groups that are likely to benefit from a specific medicine.
What Can Preome Industries Do to Help?
Preome’s predictive signatures and super biomarkers are created by combining multiple sources of data, including clinical and genomic data, and machine learning technology. By doing so, Preome can quickly create super biomarkers that can be used during early development stages, allowing researchers to stratify patients much earlier in the process. This is a significant improvement over current methods, which require post-approval and late-stage development for accurate patient stratification.
Preome Industries is a game-changer in the field of drug development, helping to improve the clinical success of medicines. With their predictive super signatures and super biomarkers, Preome can provide reliable indicators of a medicine’s future clinical success. This can help companies make more informed decisions and improve the speed and success rates of translating medicines through clinical development. If you’re interested in learning more about Preome, be sure to check out their website and follow them on social media to stay up to date on their latest developments.
Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.